All News

The FDA approval of Breyanzi, a CAR-T cell therapy, offers patients with relapsed/refractory lymphoma the opportunity for long-term remission, and hope for a cure, one expert said.

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.

The stories in this issue of CURE illustrate how patients with cancer have become partners in therapeutic advances.

My oncology nurse has been making connections with her patients for more than 20 years. I’m forever grateful I was lucky to be her patient.

Treatment with an experimental drug delivered through a minimally invasive procedure may show promise in patients with liver cancer that cannot be treated with surgery.

I can’t imagine my daughter not getting important cancer treatments because we could not afford it or because insurance denied it. Unfortunately, that is the situation for many patients.

From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Care teams often implant a chemo port into patients with cancer to provide easy access for blood draws and to deliver treatments such as chemotherapy and antibiotics. Here, as part of its Heal at Home series, CURE® works with a nurse to provide a guide for patients to care for their port.

Recent clinical trial results have given me new hope that one day soon, a cure for all cancers will be found.

Tafinlar plus Mekinist is now approved by the Food and Drug Administration to treat adults and children over the age of 6 who have BRAF V600-mutant advanced solid cancers.

In CURE®’s “Speaking Out” video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for brain metastases in breast cancer and how patients can take part in driving their care.

The FDA approval of the first poly (adenosine diphosphate-ribose) polymerase, or PARP, inhibitor in the 2010s has drastically changed how patients with gynecologic cancers are treated.

I was lucky to find a cancer resource center that offered support groups, free wigs and plenty more — including delicious luncheons for survivors and their families.

Cancer treatment has evolved over the past 20 years, but has the way it is depicted in television and movies also changed?

Long-term follow-up shows that the CAR-T cell therapy Tecartus continues to elicit durable responses in patients with relapsed/refractory mantle cell lymphoma.

Looking back, perhaps a poem could have helped me tell my family about my cancer diagnosis.

Many patients with cancer who have limited financial resources or high insurance co-pays have started to use crowdfunding campaigns to pay for the daunting bills associated with their treatment and subsequent care.

After being diagnosed with breast cancer, I struggled to discuss what was going on, but once I started a blog, the sunshine began to pour in.

The use of newer tools and techniques may be reducing the risk of surgical site infections and other complications in patients receiving treatment for gynecologic cancers.

Sierra Oncology noted in a company-issued press release that if momelotinib is approved by the FDA that they anticipate making the drug available to patients with myelofibrosis next year.

It is incredibly important that patients with MPNs inform their health care team of any symptoms they are experiencing, according to an expert from The Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center.

People are always shocked when I tell them I am a breast cancer survivor, highlighting the need to discuss the fact that people under the age of 40 can be diagnosed, too.

It has been 46 years since my brother died of cancer, and I have finally reached the “bitter resentment” stage of grief.

Recent study findings demonstrate that certain older women with breast cancer may be able to skip chemotherapy after treatment with endocrine therapy.

One patient turned her diagnosis of multiple myeloma into a way to educate others as an advocate.

Day after day, patients come in to receive chemotherapy treatment, passing rooms with warning signs and hospital staff in protective isolation gear. They want to know they are safe.